|
Recent Developments |
|
29-JAN-15
During the quarter, the profit of the company declined 8.85% to Rs 93.70 million from Rs 102.80 million in the same quarter last year.
02-JUL-13
Hikal has signed a long term pharmaceutical supply contract with a global biopharmaceutical company. It has preferred long-term outsourcing partner for leading global life sciences companies
12-JUN-13
Hikal announced that HIkal Employee Welfare Trust A and HIkal Employee Welfare Trust B wer... More.. |
| Business Profile |
Future Plans |
|
| CEO Talk | | In a five-year span we should have a compound growth of 25% both in top line and bottom line Jai Hiremath |
|
|
One To One
|
|
Recent news
|
|
|
| Brief Financials (in Rs. Mn.) | |
| Period ending (months) | 31-Mar-2016(12) | 31-Mar-2015 (12) | 31-Mar-2014 (12) | | Net sales | 9256.50 | 8718.60 | 8292.10 | | Other Income | 18.40 | 15.70 | 340.80 | | Total Income | 9274.90 | 8734.30 | 8632.90 | | Cost of goods sold | 7620.90 | 6893.40 | 6372.20 | | OPBDIT | 1654.00 | 1840.90 | 2260.70 | | PAT | 413.00 | 405.20 | 640.80 | | Gross Block | - | - | - | | Equity capital | 164.40 | 164.40 | 164.40 | | EPS (Rs.) | - | 4.93 | 38.98 | | DPS (Rs.) | - | - | - | | BV (Rs.) | - | - | - | | P/E range (x) | - | 23.73 - 169.37 | 9.24 - 14.26 | | Debt / Equity (x) | - | - | - | | Operating margin (% of OI) | 17.8 | 21.1 | 26.2 | | Net margin (% of OI) | 4.5 | 4.6 | 7.4 |
|
|
Detailed Financials
|
|
|
|
|
